Posted on March 25, 20263/25/26
Solving The Rare Disease Launch Paradox — Using Pre‑Launch Planning and Partnership to Create Value
Posted on February 26, 20262/26/26
Recognizing Rare Disease Day: Advancing Hope, Access and Innovation
Posted on October 16, 202510/16/25
Identifying Challenges and Solutions for Indirect Comparisons in Myasthenia Gravis
Posted on March 27, 20253/27/25
Optimizing Specialty Pharmacy Networks: A Best-in-Class Approach for Rare Disease Therapies
Posted on March 21, 20253/21/25
Overcoming the Odds: How EVERSANA Helped a Family Navigate Their Rare Disease Journey
Posted on March 19, 20253/19/25
Rare Disease Care in India: A Path to Positive Impact
Posted on February 28, 20252/28/25
Successfully Navigating the Complexity of Market Access Across Europe to Improve Health Equity
Posted on September 19, 20239/19/23
New Models of Benefits Verification Solve for Complexity, Accelerate Speed to Therapy and Deliver Price Transparency
Posted on June 16, 20236/16/23
Digital Guide to Commercializing Complex Therapeutics
Posted on June 13, 20236/13/23